Jordan Berlin MD

Oncology•Nashville, TN

Gastrointestinal Cancer, Hematologic Oncology

Professor, Medicine, Vanderbilt University School of Medicine

Join to View Full Profile

3601 21st Ave SNashville, TN 37232
Phone+1 615-322-3000
Fax+1 615-343-7602

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1992 - 1995
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1989 - 1992
University of Illinois College of MedicineClass of 1989

Certifications & Licensure

TN State Medical License 1999 - 2027
AL State Medical License 2020 - 2020
IL State Medical License 1995 - 1999
WI State Medical License 1992 - 1999
OH State Medical License 1991 - 1992
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
Nashville Lifestyles Magazine Castle Connolly, 2011, 2013-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Doxorubicin and Bortezomib in Treating Patients With Liver Cancer Start of enrollment: 2004 Mar 01
Completed
Phase 2
Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors Start of enrollment: 2007 Jul 01
Terminated
Phase 1
Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer Start of enrollment: 2007 Jun 01
Completed
Phase 1
Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery Start of enrollment: 2011 Dec 12
Completed
Phase 1, Phase 2
Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal Cancer Start of enrollment: 2013 Feb 12
Terminated
Phase 1, Phase 2
Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer Start of enrollment: 2012 Nov 23
Completed
Phase 2
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors Start of enrollment: 2013 Mar 29
Completed
Phase 1
A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer Start of enrollment: 2013 Sep 01
Completed
Phase 1
Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors
TERMINATED
PHASE1
First in Human Study of M4344 in Participants With Advanced Solid Tumors Start of enrollment: 2015 Jan 26
Completed
Phase 1
Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies Start of enrollment: 2016 Nov 01
Terminated
Phase 1, Phase 2
Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer Start of enrollment: 2017 Aug 23
COMPLETED
PHASE1, PHASE2
Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer Start of enrollment: 2020 Nov 16
ACTIVE_NOT_RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

9 citations
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours.
Howard A Burris, Jordan Berlin, Tobias Arkenau, Gregory M Cote, Martijn P Lolkema
British Journal of Cancer. 2024-04-01
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study.
Do-Youn Oh, Maria Alsina Maqueda, David I Quinn, Peter J O'Dwyer, Ian Chau
BMC Cancer. 2023-11-03
7 citations
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance.
Christina Yap, Jan Rekowski, Moreno Ursino, Olga Solovyeva, Dhrusti Patel
BMJ. 2023-10-20

Lectures

Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
Expanding the Treatment Landscape in Hepatocellular Carcinoma
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Great Debates and Updates in Gastrointestinal Malignancies
Imedex, New York, New York - 3/30/2012
5th Symposium on Emerging Treatments & Advances in Novel Cancer Therapies for Practicing Physicians & Healthcare Professionals
CancerNet, LLC, Dallas, Texas - 1/18/2012
Join now to see all